Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-007719
Filing Date
2019-05-17
Accepted
2019-05-17 14:31:05
Documents
37
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 309647
2 ex31-1.htm EX-31.1 20251
3 ex31-2.htm EX-31.2 20262
4 ex32-1.htm EX-32.1 10890
  Complete submission text file 0001493152-19-007719.txt   1856696

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE iaso-20190331.xml EX-101.INS 191724
6 XBRL SCHEMA FILE iaso-20190331.xsd EX-101.SCH 32122
7 XBRL CALCULATION FILE iaso-20190331_cal.xml EX-101.CAL 24995
8 XBRL DEFINITION FILE iaso-20190331_def.xml EX-101.DEF 102847
9 XBRL LABEL FILE iaso-20190331_lab.xml EX-101.LAB 206548
10 XBRL PRESENTATION FILE iaso-20190331_pre.xml EX-101.PRE 145142
Mailing Address 7315 E. PEAKVIEW AVE. CENTENNIAL CO 80111
Business Address 7315 E. PEAKVIEW AVE. CENTENNIAL CO 80111 (303) 796-8940
IASO BioMed, Inc. (Filer) CIK: 0001662907 (see all company filings)

EIN.: 473474169 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-215083 | Film No.: 19835185
SIC: 2834 Pharmaceutical Preparations